Literature DB >> 9315650

The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro.

H Lu1, R P Fisher, P Bailey, A J Levine.   

Abstract

Phosphorylation is believed to be one of the mechanisms by which p53 becomes activated or stabilized in response to cellular stress. Previously, p53 was shown to interact with three components of transcription factor IIH (TFIIH): excision repair cross-complementing types 2 and 3 (ERCC2 and ERCC3) and p62. This communication demonstrates that p53 is phosphorylated by the TFIIH-associated kinase in vitro. The phosphorylation was found to be catalyzed by the highly purified kinase components of TFIIH, the CDK7-cycH-p36 trimeric complex. The phosphorylation sites were mapped to the C-terminal amino acids located between residues 311 and 393. Serines 371, 376, 378, and 392 may be the potential sites for this kinase. Phosphorylation of p53 by this kinase complex enhanced the ability of p53 to bind to the sequence-specific p53-responsive DNA element as shown by gel mobility shift assays. These results suggest that the CDK7-cycH-p36 trimeric complex of TFIIH may play a role in regulating p53 functions in cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315650      PMCID: PMC232440          DOI: 10.1128/MCB.17.10.5923

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

2.  Small peptides activate the latent sequence-specific DNA binding function of p53.

Authors:  T R Hupp; A Sparks; D P Lane
Journal:  Cell       Date:  1995-10-20       Impact factor: 41.582

3.  p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches.

Authors:  S Lee; B Elenbaas; A Levine; J Griffith
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

4.  Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.

Authors:  J Jayaraman; C Prives
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

5.  Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells.

Authors:  A Samad; C W Anderson; R B Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase.

Authors:  R P Fisher; P Jin; H M Chamberlin; D O Morgan
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  p53 modulation of TFIIH-associated nucleotide excision repair activity.

Authors:  X W Wang; H Yeh; L Schaeffer; R Roy; V Moncollin; J M Egly; Z Wang; E C Freidberg; M K Evans; B G Taffe
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

9.  Induction of the growth inhibitor IGF-binding protein 3 by p53.

Authors:  L Buckbinder; R Talbott; S Velasco-Miguel; I Takenaka; B Faha; B R Seizinger; N Kley
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

10.  In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein.

Authors:  J P Tassan; M Jaquenoud; A M Fry; S Frutiger; G J Hughes; E A Nigg
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  42 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 2.  Phosphorylation in transcription: the CTD and more.

Authors:  T Riedl; J M Egly
Journal:  Gene Expr       Date:  2000

Review 3.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 4.  Targeted gene repair -- in the arena.

Authors:  Eric B Kmiec
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation.

Authors:  Gan Wang; Lynn Chuang; Xiaohong Zhang; Stephanie Colton; Alan Dombkowski; John Reiners; Amy Diakiw; Xiaoxin Susan Xu
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

6.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.

Authors:  T Unger; T Juven-Gershon; E Moallem; M Berger; R Vogt Sionov; G Lozano; M Oren; Y Haupt
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

7.  CTD kinase I is involved in RNA polymerase I transcription.

Authors:  Céline Bouchoux; Guillaume Hautbergue; Sabrina Grenetier; Christophe Carles; Michel Riva; Valérie Goguel
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

8.  Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities.

Authors:  P Kaldis; A A Russo; H S Chou; N P Pavletich; M J Solomon
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

9.  ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Authors:  Hetal Patel; Manikandan Periyasamy; Georgina P Sava; Alexander Bondke; Brian W Slafer; Sebastian H B Kroll; Marion Barbazanges; Richard Starkey; Silvia Ottaviani; Alison Harrod; Eric O Aboagye; Laki Buluwela; Matthew J Fuchter; Anthony G M Barrett; R Charles Coombes; Simak Ali
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

10.  DNA repair and transcriptional effects of mutations in TFIIH in Drosophila development.

Authors:  Carlos Merino; Enrique Reynaud; Martha Vázquez; Mario Zurita
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.